Clinical Trials and Stand Up To Cancer
You may be a candidate for a clinical trial if you have recently been diagnosed with cancer or if your cancer has returned or is not responding to treatment.
A clinical trial is a cancer research study designed to determine the safety and effectiveness of a new treatment and is critical to its development. Cancer research allows researchers to assess the study’s risks, side effects and superiority to existing treatments and is carried out only after the treatment is determined safe and effective in laboratory and animal studies.
Results of one study showed that 85 percent of patients were interested in clinical trials; however, only 9 percent had been told that a trial was a possibility. Only approximately 3 percent to 4 percent of adults with cancer participate in clinical trials. Enrollment in a clinical trial predicted improved overall and cancer-specific survival.
Because new trials are continually underway, oncologists are not always aware of all the trials available to their patients. Therefore, patients must frequently do their own research to find clinical trials that may be right for them.
Before searching for a clinical trial, it is important to know the details of your cancer diagnosis, such as your cancer type and location; tumor size (if a solid tumor); cancer stage; and previous cancer treatments, if any.
The American Association for Cancer Research (AACR) and Stand Up To Cancer (SU2C) encourage you to use the AACR-SU2C Clinical Trials Finder, a free and confidential cancer clinical trial matching and referral service.
The database contains approximately 7,000 cancer clinical trials in the United States and Canada, including SU2C Dream Team trials.
Find a Clinical Trial
Call the AACR’s Clinical Trials Navigators toll free at 1-877-769-4829.
Learn more about the types of clinical trials:
Phase I trials are the first studies to test a new drug or drug combination in humans and are designed to establish drug safety. These studies are generally only open to individuals with advanced cancer.
Phase II trials evaluate drug effectiveness for specific cancers.
Phase III trials are designed to compare a new treatment to one or more standard treatments and are usually randomized, meaning participants are randomly divided into treatment groups and not told until the study is over whether they received a standard treatment or the new treatment.
Learn more about clinical trials:
Listen to the American Association for Cancer Research's CR podcasts. The CR podcasts are a series of free radio-style shows featuring cancer news and the people in the pages of CR magazine. Below are a selection of podcasts on clinical trials and drug development.
Learn more about clinical trials and drug development by reading articles published in the American Association for Cancer Research's CR magazine.